Pliant Therapeutics (PLRX) - Net earnings per share (EPS TTM)

Symbol and logo of brand Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics focuses on developing long-term methods to combat tissue scarring. The company's rolling annual earnings per share on this GURU.Markets platform chart visualizes this status, where the value of -1.47 records the result. The developer is implementing AI software to automate cellular screening. Simultaneously, Pliant Therapeutics is expanding into lung and liver therapy markets to minimize scientific risks.

PLRX (pliantrx.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for Pliant Rx (PLRX)

- share price and expert price forecast:
General company analysis:Pliant Therapeutics, Inc. (PLRX)
Mass-produced product of Pliant Therapeutics Inc

This indicator reflects the actual efficiency of capital management in the interests of shareholders. The formula calculates the portion of net income attributable to a single share, neutralizing time gaps between reporting periods. Analyzing the company's specific net income over 12 months allows for tracking the impact of share issuances and share buybacks on the value of the stake. For Pliant Therapeutics (PLRX), this metric is critical when scaling fibrosis therapy. Growth in this indicator would confirm the commercial success of drugs that block the proliferation of connective tissue.

Competitors of Pliant Therapeutics (PLRX)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)